Experiments for taxon Haliclona species (HALICLONIDAE)

170 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
500150	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Haliclona species (HALICLONIDAE)
260056	PHARMACOLOGY OF COMPOUND - IN VITRO	KINESIN MOTOR PROTEIN ACTIVITY INHIBITION	Haliclona species (HALICLONIDAE)	ADOCIASULFATE 10
95386	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Haliclona species (HALICLONIDAE)	PAPUAMINE
187689	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	HALICLONACYCLAMINE A
105871	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)	HALICLAMINE B
1166642	PHARMACOLOGY OF EXTRACT - IN VITRO	AGGLUTININ ACTIVITY	Haliclona species (HALICLONIDAE)
290957	VOUCHER SPECIMEN REPORTED FOR		Haliclona species (HALICLONIDAE)
120404	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	BENZENE-1-3-DIOL,5-(PENTADEC-CIS-4'-ENYL):
187693	PHARMACOLOGY OF COMPOUND - IN VITRO	PROTEIN KINASE C INHIBITION	Haliclona species (HALICLONIDAE)	HALICLONACYCLAMINE A
120411	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	BENZENE-1-3-DIOL,5-(12'-METHYL-TRIDECYL):
120405	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	BENZENE-1-3-DIOL,5-(PENTADEC-CIS-6'-ENYL):
500161	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Haliclona species (HALICLONIDAE)
95382	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Haliclona species (HALICLONIDAE)
267693	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)	HALICLAMIDE
1166638	PHARMACOLOGY OF EXTRACT - IN VITRO	HEMOLYTIC ACTIVITY	Haliclona species (HALICLONIDAE)
980447	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)
102133	PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)	MANZAMINE B
173574	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	CYCLORENIERIN B
253946	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Haliclona species (HALICLONIDAE)	PURINE,6-IMINO-1-3-DIMETHYL-2-OXO:
500153	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Haliclona species (HALICLONIDAE)
171796	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)	MANZAMINE Y
91908	UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	MANZAMINE B
1305279	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Haliclona species (HALICLONIDAE)	RENIEROSIDE C9
171797	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Haliclona species (HALICLONIDAE)	MANZAMINE B
354045	MASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Haliclona species (HALICLONIDAE)	BENZOIC ACID,4-HYDROXY:THEOPHYLLINE
290961	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Haliclona species (HALICLONIDAE)	HALAMINOL B
816497	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Haliclona species (HALICLONIDAE)
187692	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTIFUNGAL ACTIVITY	Haliclona species (HALICLONIDAE)	HALICLONACYCLAMINE A
263798	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Haliclona species (HALICLONIDAE)	HALICLOTRIOL B
980448	PHARMACOLOGY OF EXTRACT - IN VIVO	TOXICITY ASSESSMENT(QUANTITATIVE)	Haliclona species (HALICLONIDAE)
275471	VOUCHER SPECIMEN REPORTED FOR		Haliclona species (HALICLONIDAE)
500157	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Haliclona species (HALICLONIDAE)
276293	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	HALIPEPTIN A
1166641	GEL PERMEATION CHROMATOGRAPHY USEDAFFINITY CHROMATOGRAPHY USEDISOLATION AND IDENTIFICATION OF		Haliclona species (HALICLONIDAE)	HALICLONA HEMAGGLUTININ
187696	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)	HALICLONACYCLAMINE B
1305282	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Haliclona species (HALICLONIDAE)	RENIEROSIDE C12
263512	PHARMACOLOGY OF COMPOUND - IN VITRO	NEURITOGENIC ACTIVITY	Haliclona species (HALICLONIDAE)	LEMBEHYNE A
550821	IDENTIFICATION IN BY GC/MS		Haliclona species (HALICLONIDAE)	APLYSTEROL,24(28)-DIDEHYDRO:CHOLESTEROL,22-DEHYDRO: 24-METHYL:CHOLESTEROL,22-DEHYDRO: 24-ETHYL:CHOLESTEROL,24-METHYLENE:CHOLESTEROL,24-ETHYL:SPHINGOSINE,N-DOCOSYL:SPHINGOSINE,DIHYDROXY:CHIMYL ALCOHOLBATYL ALCOHOLCHOLESTEROL
260055	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	ADOCIASULFATE 10
275476	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)	MIMOSAMYCIN
1305276	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Haliclona species (HALICLONIDAE)	RENIEROSIDE C6
92931	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Haliclona species (HALICLONIDAE)	PAPUAMINE
105869	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	HALICLAMINE B
103161	PMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Haliclona species (HALICLONIDAE)	HALICEREBROSIDE A
91911	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)	MANZAMINE C
1305271	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Haliclona species (HALICLONIDAE)	RENIEROSIDE C1
105864	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)
162097	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	HALICYCLAMINE A
95383	ISOLATION AND IDENTIFICATION OF		Haliclona species (HALICLONIDAE)	PAPUAMINE
187694	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	HALICLONACYCLAMINE B
195548	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDABSOLUTE CONFIGURATION DETERMINEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	HEXACOSA-TRANS-4-TRANS-23-DIENE-1-25-DIYNE,3-HYDROXY-11-METHYL:
1166643	PHARMACOLOGY OF EXTRACT - IN VITRO	HEMOLYTIC ACTIVITY	Haliclona species (HALICLONIDAE)
500149	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Haliclona species (HALICLONIDAE)
500160	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Haliclona species (HALICLONIDAE)
95389	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Haliclona species (HALICLONIDAE)	HALICLONADIAMINE
275474	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)	QUINOLIN-6-OL,ISO: 1-HYDROXY-METHYL-7-METHOXY:
173573	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	CYCLORENIERIN A
500154	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Haliclona species (HALICLONIDAE)
170199	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	ETHYLENE SULFATE,2-(3'-4'-DIHYDROXY-PHENYL): CIS-1:
1019336	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	PYRAN,TETRAHYDRO: 2-(1'-BROMO-ETHYL)
95385	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Haliclona species (HALICLONIDAE)	PAPUAMINE
1305274	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Haliclona species (HALICLONIDAE)	RENIEROSIDE C4
1166639	PHARMACOLOGY OF EXTRACT - IN VITRO	FISH POISON	Haliclona species (HALICLONIDAE)
105872	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)	HALICLAMINE B
816499	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Haliclona species (HALICLONIDAE)	TAURINE
102136	ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED		Haliclona species (HALICLONIDAE)	MANZAMINE D
1305285	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTICRUSTACEAN ACTIVITY	Haliclona species (HALICLONIDAE)
1305168	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)	HALICLONIA PYRIDIUNIUM,3-ALKYL DIMER
120401	VOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Haliclona species (HALICLONIDAE)	GREVILLOL
263509	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORCOMPOUND ISOLATED HAS UNUSUAL NAME		Haliclona species (HALICLONIDAE)	LEMBEHYNE A
1305280	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Haliclona species (HALICLONIDAE)	RENIEROSIDE C10
1305167	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Haliclona species (HALICLONIDAE)	HALICLONIA PYRIDIUNIUM,3-ALKYL TRIMER
89388	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)	MENZAMINE A
267692	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Haliclona species (HALICLONIDAE)	HALICLAMIDE
1166640	PHARMACOLOGY OF EXTRACT - IN VIVO	TOXIC EFFECT(GENERAL)	Haliclona species (HALICLONIDAE)
252133	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	HALICLONYNE
263797	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	HALICLOTRIOL B
95390	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Haliclona species (HALICLONIDAE)	HALICLONADIAMINE
105868	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)	HALICLAMINE A
980449	IDENTIFICATION OF		Haliclona species (HALICLONIDAE)	HALITOXIN
1305281	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Haliclona species (HALICLONIDAE)	RENIEROSIDE C11
290962	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Haliclona species (HALICLONIDAE)	HALAMINOL C
102132	PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Haliclona species (HALICLONIDAE)	MANZAMINE B
1305275	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Haliclona species (HALICLONIDAE)	RENIEROSIDE C5
162099	PHARMACOLOGY OF COMPOUND - IN VITRO	INOSINE MONOPHOSPHATE DEHYDROGENASE INHIBITION	Haliclona species (HALICLONIDAE)	HALICYCLAMINE A
103162	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)
170198	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	ETHYLENE SULFATE,2-(3'-4'-DIHYDROXY-PHENYL): TRANS-1:
276294	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIINFLAMMATORY ACTIVITY	Haliclona species (HALICLONIDAE)	HALIPEPTIN A
187695	PHARMACOLOGY OF COMPOUND - IN VITRO	PROTEIN KINASE C INHIBITION	Haliclona species (HALICLONIDAE)	HALICLONACYCLAMINE B
120408	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	BENZENE-1-3-DIOL,5-(NONADECA-CIS-7'-CIS-10'-CIS-13'-CIS-16'-TETRAENYL):
95384	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Haliclona species (HALICLONIDAE)	PAPUAMINE
263511	PHARMACOLOGY OF COMPOUND - IN VITRO	NEURITOGENIC ACTIVITY	Haliclona species (HALICLONIDAE)	LEMBEHYNE A
275477	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)	MIMOSAMYCIN
500158	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Haliclona species (HALICLONIDAE)
197048	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	HALICLOSTANONE SULFATE
290959	PHARMACOLOGY OF EXTRACT - IN VITRO	LARVICIDAL ACTIVITY	Haliclona species (HALICLONIDAE)
275473	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)	QUINOLIN-6-OL,ISO: 1-HYDROXY-METHYL-7-METHOXY:
187698	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTIFUNGAL ACTIVITY	Haliclona species (HALICLONIDAE)	HALICLONACYCLAMINE B
500152	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Haliclona species (HALICLONIDAE)
170197	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	ETHANE,2-(3'-4'-DIHYDROXY-PHENYL)-1-1-2-TRIMETHOXY:
500148	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Haliclona species (HALICLONIDAE)
197049	CMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Haliclona species (HALICLONIDAE)	HALISTANOL SULFATE
95388	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Haliclona species (HALICLONIDAE)	HALICLONADIAMINE
221477	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Haliclona species (HALICLONIDAE)	HALICLONACYCLAMINE D
102135	PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)	MANZAMINE C
1166644	PHARMACOLOGY OF EXTRACT - IN VITRO	FISH POISON	Haliclona species (HALICLONIDAE)
120402	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Haliclona species (HALICLONIDAE)	BILOBOL
179072	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORCOMPOUND ISOLATED HAS UNUSUAL NAME		Haliclona species (HALICLONIDAE)	ROTTNESTOL
1305169	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)	HALICLONIA PYRIDIUNIUM,3-ALKYL TRIMER
221474	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Haliclona species (HALICLONIDAE)	HALCLONACYCLAMINE A
187690	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)	HALICLONACYCLAMINE A
1019337	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	PYRAN,TETRAHYDRO: 2-(1'-BROMO-ETHYL)-2-(S)-5-(R)-DIMETHYL-6-(R)-(PENTA-4''-ENYL):
500159	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Haliclona species (HALICLONIDAE)
1305273	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Haliclona species (HALICLONIDAE)	RENIEROSIDE C3
263510	PHARMACOLOGY OF EXTRACT - IN VITRO	NEURITOGENIC ACTIVITY	Haliclona species (HALICLONIDAE)	LEMBEHYNE A
1305284	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Haliclona species (HALICLONIDAE)	RENIEROSIDE C14
816498	VOUCHER SPECIMEN REPORTED FORYIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Haliclona species (HALICLONIDAE)	AZETIDINE-2-CARBOXYLIC ACID,L:
171795	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	MANZAMINE Y
500147	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Haliclona species (HALICLONIDAE)
260058	PHARMACOLOGY OF COMPOUND - IN VITRO	KINESIN MOTOR PROTEIN ACTIVITY INHIBITION	Haliclona species (HALICLONIDAE)	ADOCIASULFATE 2
89387	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Haliclona species (HALICLONIDAE)	MENZAMINE A
500155	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Haliclona species (HALICLONIDAE)
276295	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Haliclona species (HALICLONIDAE)	HALIPEPTIN B
1305166	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Haliclona species (HALICLONIDAE)	HALICLONIA PYRIDIUNIUM,3-ALKYL DIMER
120407	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	BENZENE-1-3-DIOL,5-(HEPTADECA-CIS-8'-CIS-11'-DIENYL):
212825	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	SALICYLIHALAMIDE B
162098	PHARMACOLOGY OF EXTRACT - IN VITRO	INOSINE MONOPHOSPHATE DEHYDROGENASE INHIBITION	Haliclona species (HALICLONIDAE)
105867	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)	HALICLAMINE A
91909	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)	MANZAMINE B
263796	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	HALICLOTRIOL A
187697	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Haliclona species (HALICLONIDAE)	HALICLONACYCLAMINE B
290958	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIFUNGAL ACTIVITY	Haliclona species (HALICLONIDAE)
500151	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Haliclona species (HALICLONIDAE)
120403	CMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Haliclona species (HALICLONIDAE)	BENZENE-1-3-DIOL,5-(HEPTADECA-CIS-5'-CIS-8'-CIS-11'-CIS-14'-TETRAENYL):
1305278	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Haliclona species (HALICLONIDAE)	RENIEROSIDE C8
195549	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	HEXACOSA-CIS-3-CIS-23-DIENE-1-25-DIYNE,METHYL:
195550	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	DOCOSA-CIS-3-EN-1-YNE,14-METHYL:
95387	UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	HALICLONADIAMINE
120410	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	BENZENE-1-3-DIOL,5(HENEICOSA-CIS-3'-CIS-6'-CIS-9'-CIS-12'-CIS-15'-CIS-18'-HEXAENYL):
102134	PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Haliclona species (HALICLONIDAE)	MANZAMINE C
105870	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)	HALICLAMINE B
1166637	PHARMACOLOGY OF EXTRACT - IN VITRO	AGGLUTININ ACTIVITY	Haliclona species (HALICLONIDAE)
105865	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	HALICLAMINE A
212823	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	SALICYLIHALAMIDE A
170196	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF		Haliclona species (HALICLONIDAE)	HALICLONADIAMINEPAPUAMINE
1166645	PHARMACOLOGY OF EXTRACT - IN VIVO	TOXIC EFFECT(GENERAL)	Haliclona species (HALICLONIDAE)
91910	UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	MANZAMINE C
1305272	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Haliclona species (HALICLONIDAE)	RENIEROSIDE C2
105866	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)	HALICLAMINE A
171798	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Haliclona species (HALICLONIDAE)	MANZAMINE C
275472	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)	QUINOLIN-6-OL,ISO: 1-HYDROXY-METHYL-7-METHOXY:
120406	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	BENZENE-1-3-DIOL,5-(HEPTADECA-CIS-8'-CIS-11'-CIS-14'-TRIENYL):
221476	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	HALICLONACYCLAMINE C
221475	X-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Haliclona species (HALICLONIDAE)	HALICLONACYCLAMINE B
105863	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)
290960	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Haliclona species (HALICLONIDAE)	HALAMINOL A
275475	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Haliclona species (HALICLONIDAE)	MIMOSAMYCIN
212824	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)	SALICYLIHALAMIDE A
1305165	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)
102137	PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Haliclona species (HALICLONIDAE)	MANZAMINE D
260057	ISOLATION AND IDENTIFICATION OF		Haliclona species (HALICLONIDAE)	ADOCIASULFATE 4ADOCIASULFATE 3ADOCIASULFATE 2ADOCIASULFATE 1ADOCIASULFATE 6ADOCIASULFATE 5
92930	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	PAPUAMINE
187691	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Haliclona species (HALICLONIDAE)	HALICLONACYCLAMINE A
1305283	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Haliclona species (HALICLONIDAE)	RENIEROSIDE C13
1305277	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Haliclona species (HALICLONIDAE)	RENIEROSIDE C7
253947	ISOLATION AND IDENTIFICATION OF		Haliclona species (HALICLONIDAE)	THEOPHYLLINE
500156	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Haliclona species (HALICLONIDAE)
263799	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Haliclona species (HALICLONIDAE)	HALICLOTRIOL B
120409	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Haliclona species (HALICLONIDAE)	BENZENE-1-3-DIOL,5-(NONADECA-CIS-4'-CIS-7'-CIS-10'-CIS-13'-CIS-16'-PENTAENYL):
550822	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Haliclona species (HALICLONIDAE)

Experiments for taxon Haliclona species (HALICLONIDAE)

Experiments (170 results)

Filters

Worktypes (24)

Pharmacology (18)

Compounds (95)

Organisms (37)